IO Vancomycin Spine

Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Methodist Hospital Research Institute

About this trial

The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusion surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient is undergoing open posterior instrumented spinal fusion (PSIF) or transforaminal lumbar interbody fusion (TLIF)

Patient is able to give informed consent to participate on the study. LAR consents will not be utilized for this study

Age Range >18

Disqualifiers

Previous spine surgery if surgeon deems it will affect the study

BMI > 40

Contraindication to receiving vancomycin, cefepime, ancef, or other standard of care pre-operative antibiotic (allergy, medical issue, etc).

Inability to administer the IO infusion

Trial design

Design model

Parallel

Treatments tested in this trial

  • Intraosseous Vancomycin

    Drug

    The intervention is specific to the method of administration that will be used when giving the dose of antibiotic vancomycin which is done to prevent infection following surgery.

  • Intravenous Vancomycin

    Drug

    This is the standard method of giving the antibiotic vancomycin to patients undergoing surgery across many specialties in order to prevent infection.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Intraosseous VancomycinExperimental treatment 1 intervention
Group B: Intravenous VancomycinActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Level of Systemic Vancomycin Concentration

The level of vancomycin concentration will be assessed via a blood draw by the anesthesiologist staff.

Time frame
Start of skin incision during surgery, Start of closure of skin incision during surgery
2

Level of Vancomycin Concentration in Bone

Bony tissue samples (Superior Articular Process, Inferior Articular Process, and Lamina) will be taken during surgery to assess levels of vancomycin concentration in the bone.

Time frame
During surgery
3

Level of Vancomycin Concentration in Soft Tissue

Soft tissue samples (Multifidus muscle, Fat) will be taken during surgery to assess levels of vancomycin concentration in the tissue.

Time frame
During surgery

Secondary outcomes

1

Post-Operative Complication Rates

Participant's charts will be reviewed postoperatively to determine if there were any adverse local/systemic reactions and/or complications following the surgery.

Time frame
30 Days Post Surgery, 90 Days Post Surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: